RSS

Archive | Pradaxa RSS feed for this section

Pradaxa Lawsuits Settles For $650 Million

30. May 2014

0 Comments

Boehringer Ingelheim Settles US Pradaxa Litigation For $650 Million Boehringer Ingelheim will pay $650 million in a “comprehensive settlement” of lawsuits over Pradaxa drug. The company said that it expects the settlement will resolve about 4,000 current cases against the company in the US. Pradaxa has been bedeviled by reports of excessive bleeding complications. Following […]

Continue reading...

Pradaxa Lawsuit

13. February 2012

0 Comments

Pradaxa (dabigatran etexilate mesylate) is a new blood thinning drug manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is in a class of drugs called Direct Thrombin Inhibitors, otherwise known as anticoagulants or blood thinners.  Pradaxa was approved by the FDA in October of 2010 as a blood thinner that was superior to Warfarin because it allegedly […]

Continue reading...